<DOC>
	<DOCNO>NCT00950651</DOCNO>
	<brief_summary>A randomised , multi-centre , double-blind , double dummy , two arm parallel design study compare efficacy , safety , clinical benefit test reference product treatment 84 day patient osteoarthritis knee .</brief_summary>
	<brief_title>A Comparison Analgesic Efficacy Safety Once Daily Tramadol HCl / ContramidÂ® Tablets Twice Daily Tramadol HCl ( SR ) Treatment Osteoarthritis Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>1 . Males Females age 40 75 diagnosis Osteoarthritis ( OA ) knee consistent American College Rheumatology ( ACR ) Clinical Classification Criteria Arthritis Knee ( Altman , R. et al. , 1986 ) : Knee pain study enrolment , Less 30 minute morning stiffness without crepitus active motion . Confirmation either arthroscopy radiologist 's report ( Xrays show osteophyte , joint space narrow subchondral bone sclerosis { eburnation } ) within 1 year prior entry study . 2 . ESR &lt; 40 mm/h 3 . Western Ontario McMaster University Osteoarthritis Index ( WOMAC ) Pain Subscales total score equal 150 mm baseline . 4 . Oral write language comprehension level sufficient comply protocol complete studyrelated material . 5 . The Patient sign date ( IEC ) approve , write , informed consent prior study participation 1 . Known rheumatoid arthritis rheumatoid disease . 2 . Secondary arthritis i.e . follow : septic arthritis ; inflammatory joint disease ; gout ; pseudogout ; Paget 's disease ; joint fracture ; acromegaly ; fibromyalgia ; Wilson 's disease ; Ochronosis ; Haemochromatosis ; Osteochondromatosis ; heritable arthritic disorder ; collagen gene mutation . 3 . Obesity Class II [ body mass index ( BMI ) equal 35 kg/m2 ] ( NIH , 2000 ) 4 . Major illness require hospitalisation 3 month commencement screening period . 5 . Unwillingness cease take medication study medication arthritic pain , concomitant pain , OA medication . 6 . Patients previously fail tramadol HCl therapy discontinue tramadol HCl due AEs . 7 . Patients within 3 week prior study entry take follow medication : monoamine oxidase inhibitor ; tricyclic antidepressant tricyclic compound ( e.g . cyclobenzaprine , promethazine ) ; neuroleptic ; selective serotonin reuptake inhibitor ; drug reduce seizure threshold . 8 . Patients take another investigational agent within 30 day prior study entry . 9 . Patients history seizure disorder Infantile Febrile Seizures . 10 . Patients opioid dependent . 11 . Patients bowel disease cause malabsorption . 12 . Patients pregnant lactate patient childbearing potential unwilling utilise medically approve method contraception participation clinical trial . 13 . Patients significant liver disease , define active hepatitis elevate liver enzymes &gt; 3 time upper boundary normal range . 14 . Patients significant renal disease , define creatinine clearance &lt; 30 mL/min estimate method Levey et al. , 1999 . 15 . Current substance abuse dependence , nicotine . 16 . Allergy adverse reaction tramadol structurally similar drug e.g . opiate . 17 . Any condition , opinion investigator , adversely affect patient 's ability complete study measure .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>